Health Care/Hospital
Gilead Sciences' Pulse Survey Highlights Majority of People Living with HIV, Individuals at Risk and HIV Care Prescribers in Asia Pacific Experience Disruptions in HIV Care During COVID-19 Pandemic
HONG KONG, Nov. 30, 2020 /PRNewswire/ -- Gilead Sciences, Inc. today announced findings from a pulse survey conducted to evaluate the impact of the COVID-19 pandemic on the access and delivery of care in HIV, which includes testing, treatment and prevention, inAsia Pacific. The survey revealed ...
2020-11-30 10:40
6040
Ascentage Pharma Enters into an Agreement with University of Michigan to obtain an exclusive license for a MDM2 Degrader using PROTAC Technology
SUZHOU, China and ROCKVILLE, Md., Nov. 30, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced it has entered into an ag...
2020-11-30 08:09
2231
Gannex Appoints Former Takeda Head of Liver Disease Clinical Development Melissa Palmer, MD as Chief Medical Officer
SHANGHAI, Nov. 30, 2020 /PRNewswire/ -- Gannex, a wholly owned company of Ascletis Pharma Inc. (HKEX:1672) and fully dedicated to the R&D and commercialization of new drugs in the field of NASH, announced today that Melissa Palmer, MD, an internationally renowned Hepatologist, will join the Compa...
2020-11-30 08:00
2711
Kalkine Pty Limited To Launch its 'Australian Equity Technical Analysis Report'
SYDNEY, Nov. 30, 2020 /PRNewswire/ -- Kalkine Pty Limited is pleased to announce the launch of a new technical analysis-driven research product 'Technical Analysis Report'. This report aims to evaluate equity opportunities in consideration of sufficient risk-appetite and financial flexibility, and...
2020-11-30 06:00
2191
Varian Partners with Sony Foundation Australia in the You Can Stay Program
PALO ALTO, Calif., Nov. 30, 2020 /PRNewswire/ -- Varian (NYSE: VAR) today announced it has entered a partnership with Sony Foundation Australia to support its You Can Stay Program. The You Can Stay program provides free accommodations for cancer patients aged between 15 to 25 and their families i...
2020-11-30 05:15
3634
Eluminex Biosciences, an Ophthalmology-Focused Biotechnology Company, Announces Closing of $50 Million Series A Financing
* Proceeds to fund development of novel and best-in-class therapeutics for eye diseases * Charles Semba, MD, joins the company to serve as Chief Medical Officer SHANGHAI, Nov. 27, 2020 /PRNewswire/ -- Eluminex Biosciences Limited (Eluminex), an ophthalmic biotechnology company committed to th...
2020-11-27 21:00
3829
Sedana Medical submits market approval application for the drug Sedaconda
STOCKHOLM, Nov. 27, 2020 /PRNewswire/ -- Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announced that the company has submitted an application for market approval for the drug candidate Sedaconda (isoflurane), formerly known as IsoConDa, for inhaled sedation in intensive care. The applica...
2020-11-27 20:35
2687
Covid-19 Survivor: Showing Different Symptoms, Food Intake is Important in the Recovery Process
* Discipline in adhering to health protocols is a shared responsibility JAKARTA, Indonesia, Nov. 27, 2020 /PRNewswire/ -- All parties must adhere to health protocols as best they can in order to keep the Covid-19 transmission low. In addition, everyone must always maintain a strong immune syste...
2020-11-27 15:59
1853
Nanoform Finland Plc, Interim Report January - September 2020, November 27th, 2020 at 08:00 a.m. Finnish time
HELSINKI, Nov. 27, 2020 /PRNewswire/ -- Strong momentum continues: first GMP campaign initiated, first dosing in humans to start before year-end, all near-term business targets set out in IPO to be achieved ahead of schedule, new global major pharma client signed, two new PoC projects started, on...
2020-11-27 14:30
5861
Kingston Partners with CSD in APAC to Unleash the Power of Memories
TAIPEI, Nov. 27, 2020 /PRNewswire/ -- Moving forward its vision of preserving memories, Kingston Technology, a world leader of memory products and technology solutions, announced a creative alliance with CSD, a leading brand of face masks, to kickstart a one of a kind initiative, Kingston x CSD A...
2020-11-27 14:16
2363
Nanoform launches technology for biologics and sets new near-term business target for 2021
HELSINKI, Nov. 27, 2020 /PRNewswire/ -- Nanoform Finland Plc ("Nanoform"), an innovative nanoparticle medicine enabling company, today announced a proprietary technology that can form biological nanoparticles as small as 50 nm and announced a new near-term business target for 2021 to deliver its ...
2020-11-27 14:04
1768
NaviFUS highlights clinical trial data and device capabilities at virtual International Focused Ultrasound Symposium
TAIPEI, Nov. 27, 2020 /PRNewswire/ -- The 7th International Focused Ultrasound Symposium organized by the U.S. Focused Ultrasound Foundation took place from 11/9 to 11/13 in virtual format this year due to the Covid-19 epidemic. During the 5-day conference, participants presented and exchanged in...
2020-11-27 12:21
1456
Amorepacific Develops an Original Technology That Reverses the Aging of Skin Cells in Joint Research with KAIST
SEOUL, South Korea, Nov. 27, 2020 /PRNewswire/ -- Amorepacific R&D Center, together with KAIST, developed an original technology that reverses the aging process in human dermal fibroblasts. The system's biology research was conducted in collaboration with a research team led by ProfessorCho Kwang...
2020-11-27 09:00
2764
European Medicines Agency Validates Application for Tepotinib for the Treatment of Advanced NSCLC with METex14 Skipping Alterations
DARMSTADT, Germany, Nov. 27, 2020 /PRNewswire/ -- Merck, a leading science and technology company, today announced that the European Medicines Agency (EMA) has validated for review, the application for tepotinib for the treatment of adult patients with advanced non-small cell lung cancer (NSCLC) ...
2020-11-27 08:42
2373
Haoma Medica Completes First-in-Human Trial for NaQuinate, a Novel Treatment in Development for Osteoporosis
LONDON, Nov. 27, 2020 /PRNewswire/ -- Haoma Medica announced today the completion of a first-in-human trial for NaQuinate, a naphthoquinone carboxylic acid, which is being developed as a novel orally administered therapeutic for osteoporosis. The first-in-human trial initiated last year in heal...
2020-11-27 08:39
2221
Nose Filler Injection Can Cause Vision Loss When Injected With Poor Injection Techniques & Without Understanding Of Facial Anatomy, Dr Ivan Puah Warns
SINGAPORE, Nov. 26, 2020 /PRNewswire/ -- Dermal fillers using hyaluronic acid is one of the common types of soft-tissue augmentation used inSingapore for nose enhancement. Medical Director of Amaris B. Clinic, DrIvan Puah warns that when inexperienced medical injectors or non-medical professio...
2020-11-26 22:07
2494
China.org.cn: Seminar calls for global poverty reduction innovation, cooperation amidst pandemic
BEIJING, Nov. 26, 2020 /PRNewswire/ -- The 2020 International Seminar on Global Poverty Reduction Partnerships was held in Longnan city,Gansu province, China, onNov. 24. More than 100 participants from governments, academia, international organizations, NGOs, and the private sector attended the s...
2020-11-26 22:00
1799
Breakthrough in AML Treatment: GoldenBiotech Reports New Drug Trial of Antroquinonol -Outperforms Listing Drugs in Relapsed Acute Myeloid Leukemia
TAIPEI, Nov. 26, 2020 /PRNewswire/ -- Golden Biotechnology Corp.(GoldenBiotech, 4132.TWO), a leading Taiwanese biopharmaceutical company, announces that its new drug Antroquinonol (HOCENA®) outperforms the other listing drugs for the treatment of relapsed AML (acute myeloid leukemia) patients in ...
2020-11-26 21:35
2231
Luye Pharma and Distriphil Enter Exclusive Distribution Partnership in the Philippines with Joint Commitment to Raising Mental Health Awareness
* Luye Pharma grants Distriphil exclusive distribution and marketing rights for Seroquel® and Seroquel XR® in the Philippines * Two companies pledge to make joint effort to raise awareness of mental health issues as part of the "We Care About Mental Health" initiative SHANGHAI, Nov. 26, 2020 ...
2020-11-26 16:44
5651
Singapore-based Hello Health Group announce appointment of John Davison as Vice-Chairman
SINGAPORE, Nov. 26, 2020 /PRNewswire/ -- Hello Health Group, a leading Digital Health company inAsia focusing on the development of health and wellness information platforms and services in local languages for consumers and patients, is excited to announce the appointment ofJohn Davison as Vice-...
2020-11-26 16:40
2728
Week's Top Stories
Most Reposted
Earth Day 2024: Angel Yeast Continues to Tackle Plastic Pollution Challenges With Bio-based Material Solutions
[Picked up by 294 media titles]
2024-04-22 16:00
Trina Solar and PetroGreen Partner to Accelerate Philippine Solar Adoption with 117MW Supply Agreement
[Picked up by 291 media titles]
2024-04-22 06:00
China's Yiwu Establishes Welcoming Committee to Attract International Buyers
[Picked up by 286 media titles]
2024-04-19 13:25
Revenue Surpasses 50 Billion: BlueFocus Accelerates Towards the AI Native Era
[Picked up by 275 media titles]
2024-04-23 15:43
INTAMSYS Becomes 3D Printing Equipment Supplier for the WORLDSKILLS LYON 2024 COMPETITION
[Picked up by 272 media titles]
2024-04-24 17:09
Most Read
Combining Sustainability and Cybersecurity: Century Iron & Steel and Century Wind Power Both Receive ISO 27001 Information Security Certification
2024-04-19 18:03
9195
China's Yiwu Establishes Welcoming Committee to Attract International Buyers
2024-04-19 13:25
7769
Automation Anywhere Appoints Tim McDonough as Chief Marketing Officer to Drive Global Awareness and Growth for the Leader in AI-Powered Automation
2024-04-24 03:57
4889
